Mary B. Ajadi

Prostate-specific antigen: any successor in sight?

Aniebietabasi S Obort, Mary B. Ajadi, Oluyemi Akinloye · PubMed · 2013 · 38 citations · Full text

Medicine, Oncology, Urology +17

Thompson loop: opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein

Adeniyi T. Adewumi, Opeyemi Soremekun, Mary B. Ajadi et al. · RSC Advances · 2020 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Weak spots inhibition in the <i>Mycobacterium tuberculosis</i> antigen 85C target for antitubercular drug design through selective irreversible covalent inhibitor-SER124

Adeniyi T. Adewumi, Ahmed A. El‐Rashedy, Opeyemi Soremekun et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 27 citations

Life Sciences, Biochemistry, Pharmacology +12

Repression of HDAC5 by acetate restores hypothalamic-pituitary-ovarian function in type 2 diabetes mellitus

Kehinde S. Olaniyi, Oluwatobi A. Amusa, Isaac O. Ajadi et al. · Reproductive Toxicology · 2021 · 20 citations

Medicine, Endocrinology, Molecular Biology +14

Acetate ameliorates nephrotoxicity in streptozotocin-nicotinamide-induced diabetic rats: Involvement of xanthine oxidase activity

Kehinde S. Olaniyi, Oluwatobi A. Amusa, Nifesimi T. Akinnagbe et al. · Cytokine · 2021 · 19 citations

Medicine, Nephrology, Pharmacology +13